Crossmark

Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis

Crossref DOI link: https://doi.org/10.1186/s12931-025-03157-1

Published Online: 2025-03-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Baiyang

Liu, Senyuan

Wang, Kaiyue

Zhao, Jiarui

Li, Min

Wang, Xingpeng

Wang, Weiqing

Wang, Xiaohan

Yu, Jinming

Meng, Xue

Cai, Guoxin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82172720)

CSCO-Nav HER2-related Solid Tumors Research Foundation (Y-2022HER2AZMS-0291)

Natural Science Foundation of Shandong Province (ZR2024QH459)
License Information

Text and Data Mining valid from 2025-03-05

Version of Record valid from 2025-03-05
More Information

Article History

Received: 11 August 2024

Accepted: 15 February 2025

First Online: 5 March 2025

Declarations

:

: This study was approved by the Ethics Committee of Shandong Cancer Hospital and Institute owing to its retrospective nature with minimal risk, and informed consent was obtained from all included individuals.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below